Axonics, Inc. (AXNX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

72.74

-0.22

(-0.30%)

At close: 04:00PM EDT

73.00

+0.26

(+0.36%)

After hours:

04:31PM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bearishpattern detected

Short-term KST

View all chart patterns

Performance Outlook

Previous Close	72.96
Open	72.88
Bid	69.58 x 900
Ask	73.00 x 900
Day's Range	70.69 - 72.98
52 Week Range	38.41 - 79.81
Volume	579,339
Avg. Volume	596,654

Market Cap	3.554B
Beta (5Y Monthly)	0.45
PE Ratio (TTM)	N/A
EPS (TTM)	-1.80
Earnings Date	Nov 02, 2022 - Nov 07, 2022
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	85.25

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for AXNX

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

Axonics, Inc.
Analyst Report: Silk Road Medical IncBased in Sunnyvale, California, Silk Road Medical is a medical device company focused on reducing the risk of stroke and its devastating impact. The company has pioneered a new approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR combines the surgical principles of neuroprotection with minimally invasive endovascular techniques to treat carotid artery blockages that may cause strokes. The TCAR procedure involves threading a balloon catheter into the carotid artery from an incision near the groin to expand the narrowed artery. In parallel with the catheter procedure, another device is deployed to temporarily reverse blood flow to the brain in the treated artery in order to prevent any broken off clots from moving to the brain.
Rating
Fair Value
Economic Moat
last monthArgus Research

All

Business Wire
Axonics® to Participate in September Investor Conferences
IRVINE, Calif., August 18, 2022--Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced that senior management is scheduled to present at the following investor conferences:
- W&T Offshore Announces Participation in Upcoming Investor Events
  GlobeNewswire
- Battery Metals Virtual Investor Conference Agenda Announced for August 23rd
  GlobeNewswire
Business Wire
Axonics® Expands Sacral Neuromodulation Intellectual Property Portfolio
IRVINE, Calif., August 17, 2022--Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced that in the last twelve months, the United States Patent and Trademark Office has granted eight patents and allowed four patent applications related to the company’s sacral neuromodulation technology.
Zacks
Here's Why Axonics Modulation Technologies (AXNX) is a Great Momentum Stock to Buy
Does Axonics Modulation Technologies (AXNX) have what it takes to be a top stock pick for momentum investors? Let's find out.